These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37942087)

  • 1. sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology.
    Nabizadeh F
    Brain Commun; 2023; 5(6):fcad286. PubMed ID: 37942087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.
    Nabizadeh F; Seyedmirzaei H; Karami S
    Sci Rep; 2024 Jul; 14(1):15318. PubMed ID: 38961148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    Li TR; Lyu DY; Liu FQ;
    J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation.
    Ewers M; Biechele G; Suárez-Calvet M; Sacher C; Blume T; Morenas-Rodriguez E; Deming Y; Piccio L; Cruchaga C; Kleinberger G; Shaw L; Trojanowski JQ; Herms J; Dichgans M; ; Brendel M; Haass C; Franzmeier N
    EMBO Mol Med; 2020 Sep; 12(9):e12308. PubMed ID: 32790063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum.
    Shi X; Zhong X; Zhou H; Zhou N; Hu Y; Ning Y;
    Front Neurol; 2022; 13():961842. PubMed ID: 36408515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ remotely and locally facilitates Alzheimer's disease tau spreading.
    Nabizadeh F;
    Cereb Cortex; 2024 Sep; 34(9):. PubMed ID: 39329358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease.
    Wang ZB; Ma YH; Sun Y; Tan L; Wang HF; Yu JT;
    J Neuroinflammation; 2022 Dec; 19(1):316. PubMed ID: 36578067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease.
    Biel D; Suárez-Calvet M; Hager P; Rubinski A; Dewenter A; Steward A; Roemer S; Ewers M; Haass C; Brendel M; Franzmeier N;
    EMBO Mol Med; 2023 Feb; 15(2):e16987. PubMed ID: 36620941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.
    Schmitz TW; Soreq H; Poirier J; Spreng RN
    J Neurosci; 2020 Feb; 40(9):1931-1942. PubMed ID: 31915256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology.
    Sheng X; Yao Y; Huang R; Xu Y; Zhu Y; Chen L; Zhang L; Wang W; Zhuo R; Can D; Chang CF; Zhang YW; Xu H; Bu G; Zhong L; Chen XF
    J Neuroinflammation; 2021 Dec; 18(1):286. PubMed ID: 34893068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Soluble TREM2 Protect Against Alzheimer's Disease?
    Brown GC; St George-Hyslop P
    Front Aging Neurosci; 2021; 13():834697. PubMed ID: 35153729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
    Wu C; Ma YH; Hu H; Zhao B; Tan L;
    J Alzheimers Dis; 2023; 92(1):311-322. PubMed ID: 36744335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
    Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
    Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
    Wilson EN; Swarovski MS; Linortner P; Shahid M; Zuckerman AJ; Wang Q; Channappa D; Minhas PS; Mhatre SD; Plowey ED; Quinn JF; Zabetian CP; Tian L; Longo FM; Cholerton B; Montine TJ; Poston KL; Andreasson KI
    Brain; 2020 Mar; 143(3):932-943. PubMed ID: 32065223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis.
    Brendel M; Kleinberger G; Probst F; Jaworska A; Overhoff F; Blume T; Albert NL; Carlsen J; Lindner S; Gildehaus FJ; Ozmen L; Suárez-Calvet M; Bartenstein P; Baumann K; Ewers M; Herms J; Haass C; Rominger A
    Front Aging Neurosci; 2017; 9():8. PubMed ID: 28197095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.